Insiders · Profile

McClellan Michael James

EVP, Chief Financial Officer at TEVA PHARMACEUTICAL INDUSTRIES. Filing since 19 Mar 2018. CIK 0001721544

Company
Date
Role
Action
Shares
Amount
Of holding
5 Nov 2019
EVP, Chief Financial Officer
Sold, plan not stated
242
$2.14K
1.5%
18 Sep 2019
EVP, Chief Financial Officer
Sold, plan not stated
1,406
$11.01K
8.3%
18 Mar 2019
EVP, Chief Financial Officer
Sold, plan not stated
230
$3.82K
1.8%
4 Mar 2019
EVP, Chief Financial Officer
Sold, plan not stated
363
$6.13K
2.9%
5 Nov 2018
EVP, Chief Financial Officer
Sold, plan not stated
346
$7.87K
2.9%
19 Mar 2018
EVP, Chief Financial Officer
Sold, plan not stated
287
$5.13K
2.5%
6 decisions on file.